The expanded search functionality will also automatically search global clinical trials for related diseases to provide healthcare professionals with a broader picture. Credit: Monkey Business Images / Shutterstock.

Netherlands-based global health platform myTomorrows has added the ISRCTN platform to its platform’s clinical trial search functionality.

The platform now includes clinical trial information from a range of public registries endorsed by the World Health Organization, including clinicaltrials.gov and EudraCT.

Smarter leaders trust GlobalData

Report-cover

Reports AI in Drug Discovery

Buy the report

The addition has been announced alongside other updates, including embedded AI eligibility checking and usability improvements, to improve the available information on current clinical research findings on the platform.

The expanded search functionality will also automatically search global clinical trials for related diseases to provide healthcare professionals with a broader picture.

Included in the updates announced today (17 December) is myTomorrows’ new integrated AI assistant, which matches unique patient medical profiles to trial eligibility criteria. The company says that the technology reduces pre-screening time by 90%.

This is accompanied by a summarising feature, offering healthcare professionals rapid insights into a drug’s mechanism, efficacy and safety.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

myTomorrows already used AI to search government-endorsed public clinical trial registries and provide rapid patient identification and referral to suitable clinical trials or, where applicable, expanded access programmes. Before today’s announcement, it has already been used to connect more than 14,000 patients and 2,100 physicians to trials in over 40 countries.

AI is a growing trend within the clinical trial sector. Recent commentary by data and analytics provider GlobalData asserted that the integration of AI in the sector has already had an impact on data analysis, outcome prediction and drug development.

GlobalData is the parent company of Clinical Trials Arena.

According to myTomorrows CEO Michel van Harten: “These latest updates directly address the needs of healthcare professionals, who require a reliable, centralised source of trial information to bridge information gaps, streamline patient referrals and support informed decision-making.”

myTomorrows offers access to information on clinical trials across the UK, US and EU, and it will now also include clinical trials that are only registered on the ISRCTN.

The ISRCTN registry has become particularly important for UK-based clinical trials since Brexit as it includes non-commercial studies funded by the National Institute for Health Research, which are not always included in other international registries.